Jie Chen

Chinese Academy of Sciences (CAS)

Yantai University - Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University)

SCHOLARLY PAPERS

3

DOWNLOADS

137

TOTAL CITATIONS

1

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Anion Receptor-Mediated Multicomponent Synergistic Self-Assembly of Porphyrin for Efficient Phototherapy Elicit  Tumor Immunotherapy

NANOTODAY-D-22-00151
Number of pages: 22 Posted: 23 Mar 2022
Kui Wang, Jie Chen, Lin Lin, Nan Yan, Weihu Yang, Kaiyong Cai, Huayu Tian and Xuesi Chen
affiliation not provided to SSRN, Chinese Academy of Sciences (CAS), affiliation not provided to SSRN, affiliation not provided to SSRN, Chongqing University, Chongqing University, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 56 (807,872)

Abstract:

Loading...

Anion receptor, Porphyrin, self-assembly, Phototherapy, immunotherapy

2.

CD47KO/CRT Dual-Bioengineered Cell Membrane-Coated Nanovaccine Combined with Anti-PD-L1 Antibody for Boosting Tumor Immunotherapy

Number of pages: 37 Posted: 22 Aug 2022
Shengyang Liu, Jiayan Wu, Yuanji Feng, Xiaoya Guo, Tong Li, Meng Meng, Jie Chen, Daquan Chen and Huayu Tian
Yantai University, Yantai University - Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Yantai University - Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Yantai University - Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Yantai University - Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Yantai University - Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Chinese Academy of Sciences (CAS), Yantai University and Chinese Academy of Sciences (CAS)
Downloads 55 (815,133)
Citation 1

Abstract:

Loading...

CRISPR-Cas9, Dual-bioengineered cell membrane, Immune checkpoint blockade, Nanovaccine, Tumor immunotherapy

3.

MIL-100(Fe)-Based Co-Delivery Platform as Cascade Synergistic Chemotherapy and Immunotherapy Agents for Colorectal Cancer via cGAS-STING Pathway

Number of pages: 28 Posted: 15 May 2025
Pai Wang, Heshi Liu, Lei Guo, Yixin Tang, Tianwei Lan, Rui Zhou, Huiqing Xu, Lu Wang, Xue Wang, Baiqiao Chen, Yixing Wang, Siyuan Wang, Chang Liu, Jie Chen, Caina Xu, Quan Wang and Huayu Tian
Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Chinese Academy of Sciences (CAS), Jilin University (JLU) - Department of Biochemistry, Jilin University (JLU) - Department of Gastrointestinal Surgery and Chinese Academy of Sciences (CAS)
Downloads 26 (1,092,139)

Abstract:

Loading...

Colorectal Cancer, Chemotherapeutics, immunotherapy, MOF, TLR7 agonist, cGAS-STING pathway